Lobbying Activity Report

138-26018

Organization: Amgen Canada Inc.
Associated registration: 8948-138-27
Lobbying Activity date: 2023-04-25
Arranged a meeting: No
Posted date: 2023-05-13

In-house lobbyists who participated in the lobbying activity: John Snowden Footnote1
Ugur Gunaydin Footnote1
Michael Gingras Footnote1
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, Assistant Deputy Minister, Pharmaceutical, Laboratory & Blood Services Division
Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Advocacy regarding legislation, regulations, policies and programs to support innovative research and development in the pharmaceutical sector and market access for Amgen's products including as it relates to appropriate reimbursement of Amgen’s products.
  • Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
  • Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health
 
Senior officer who filed this Lobbying Activity Report: Ugur Gunaydin
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.
Date Modified: